Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

NCT06008106 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: tunlametinib
DRUG: paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin

Sponsor

Shanghai Kechow Pharma, Inc.